Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

F13A1 anticorps (AA 46-181)

F13A1 Reactivité: Humain ELISA, WB, IF, FACS, IHC (p) Hôte: Souris Monoclonal F13A1-1448 unconjugated
N° du produit ABIN5646873
  • Antigène Voir toutes F13A1 Anticorps
    F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
    Épitope
    • 22
    • 8
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 46-181
    Reactivité
    • 79
    • 8
    • 7
    • 3
    • 3
    Humain
    Hôte
    • 48
    • 31
    • 3
    • 1
    Souris
    Clonalité
    • 51
    • 32
    Monoclonal
    Conjugué
    • 52
    • 6
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp F13A1 est non-conjugé
    Application
    • 48
    • 45
    • 30
    • 30
    • 22
    • 19
    • 15
    • 8
    • 7
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    ELISA, Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purification
    Purified
    Pureté
    Protein G affinity chromatography
    Immunogène
    A human partial recombinant protein corresponding to amino acids 46-181 was used as the immunogen for the Factor XIIIa antibody.
    Clone
    F13A1-1448
    Isotype
    IgG2b kappa
    Top Product
    Discover our top product F13A1 Anticorps primaire
  • Indications d'application
    Titering of the Factor XIIIa antibody may be required for optimal performance.

    1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. ELISA: 2-4 μg/mL, order the BSA-free formulation for coating,Immunofluorescence: 1-2 μg/mL,Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Western blot: 0.5-1 μg/mL,Immunohistochemistry (FFPE): 1-2 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)

    Restrictions
    For Research Use only
  • Concentration
    1 mg/mL
    Buffer
    1 mg/mL in 1X PBS, BSA free, sodium azide free
    Agent conservateur
    Azide free
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store the Factor XIIIa antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Antigène
    F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
    Autre désignation
    Factor XIIIa / F13A1 (F13A1 Produits)
    Synonymes
    anticorps F13a, anticorps f13a1, anticorps wu:fo83d04, anticorps zgc:153334, anticorps F13A1, anticorps F13A, anticorps 1200014I03Rik, anticorps AI462306, anticorps coagulation factor XIII A1 chain, anticorps coagulation factor XIII, A1 polypeptide b, anticorps coagulation factor XIII A chain, anticorps coagulation factor XIII, A1 subunit, anticorps F13a1, anticorps f13a1b, anticorps F13A1
    Sujet
    Factor XIIIa has been identified in platelets, megakaryocytes, and fibroblast-like mesenchymal or histiocytic cells in the placenta, uterus, and prostate, monocytes and macrophages and dermal dendritic cells. Anti-Factor XIIIa has been found to be useful in differentiating between dermatofibroma (almost all cases are positive), dermatofibrosarcoma protuberans (-/+) and desmoplastic malignant melanoma (-). Anti-Factor XIIIa positivity is also seen in capillary hemagioblastoma, hemangioendothelioma, hemangiopericytoma, xanthogranuloma, xanthoma, hepatocellular carcinoma, glomus tumor, and meningioma.
Vous êtes ici:
Support technique